PCM
QGENF

Prelude Capital Management’s QIAGEN NV QGENF Stock Holding History

Prelude Capital Management’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,361
Closed -$122K – 2018
2016
Q4 		$122K Buy
4,361
+3,931
+914% +$110K 0.01% 761
2016
Q3 		$12K Buy
+430
New +$12K ﹤0.01% 1414
2014
Q4 		– Sell
-15,361
Closed -$350K – 2465
2014
Q3 		$350K Buy
15,361
+3,375
+28% +$76.9K 0.05% 502
2014
Q2 		$293K Sell
11,986
-28,160
-70% -$688K 0.04% 581
2014
Q1 		$845K Buy
40,146
+31,530
+366% +$664K 0.11% 233
2013
Q4 		$205K Sell
8,616
-30,482
-78% -$725K 0.03% 615
2013
Q3 		$841K Sell
39,098
-14,153
-27% -$304K 0.14% 181
2013
Q2 		$1.05M Buy
+53,251
New +$1.05M 0.23% 98

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Prelude Capital Management's QGENF Position: Q1 2017 in Review

Prelude Capital Management sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 4,361 shares — an estimated $122K sold.

Prelude Capital Management first reported a position in QGENF in Q2 2013 and held it in 8 quarters. The position peaked at $1.05M in Q2 2013. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Prelude Capital Management reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Prelude Capital Management sold 4,361 QIAGEN NV shares in Q1 2017, an estimated $122K.
  • Prelude Capital Management first reported a position in QIAGEN NV in Q2 2013 and held it in 8 quarters.
  • Prelude Capital Management's QIAGEN NV position peaked at $1.05M in Q2 2013.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Prelude Capital Management's 13F filing for Q1 2017, filed 15 May 2017.